This Article Full Text Full Text (PDF) All Versions of this Article: 36/7/1405    most recent 01.STR.0000170635.45745.b8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lalouschek, W. Articles by Mannhalter, C. Search for Related Content PubMed PubMed Citation Articles by Lalouschek, W. Articles by Mannhalter, C. Related Collections Arterial thrombosis Genetics of Stroke

(Stroke. 2005;36:1405.)
© 2005 American Heart Association, Inc.

Original Contributions

Matched Case-Control Study on Factor V Leiden and the Prothrombin G20210A Mutation in Patients With Ischemic Stroke/Transient Ischemic Attack Up to the Age of 60 Years

Wolfgang Lalouschek, MD; Martin Schillinger, MD; Kety Hsieh, MD; Georg Endler, MD; Susanne Tentschert; Wilfried Lang, MD; Suzanne Cheng, PhD Christine Mannhalter, PhD

From the University Clinic of Neurology (W.L., S.T.), Department of Angiology (M.S.), Clinical Institute of Medical and Chemical Laboratory Diagnostics (K.H., G.E., C.M.), Medical University Vienna (W.L., M.S., K.H., G.e., S.T., W.L., S.C., C.M.), Hospital Barmherzige Brueder (W.L.), Vienna, Austria; and the Department of Human Genetics (S.C.), Roche Molecular Systems, Inc, Alameda, Calif.

Correspondence to Wolfgang Lalouschek, MD, University Clinic of Neurology, Clinical Department of Clinical Neurology, Waehringer Guertel 18-20, 1097 Vienna, Austria. E-mail wolfgang.lalouschek{at}meduniwien.ac.at

Background and Purpose— The role of the factor V Leiden mutation (FVL) and the G20210A mutation of the prothrombin (factor II [FII]) gene for arterial thrombosis is not clear.

Methods— We investigated the prevalence of these mutations in 468 patients with an acute stroke or transient ischemic attack (TIA) before the age of 60 years and in a healthy control population individually matched for age and gender. We also analyzed interactions between the mutations, gender, standard vascular risk factors, and stroke risk.

Results— The prevalence of the FVL did not differ significantly between patients and control subjects. However, we found a significant interaction between the FVL, smoking, and risk of stroke in women: female smokers without FVL had a somewhat increased risk of stroke of 2.6 (95% CI, 1.5 to 4.6; P=0.001) compared with nonsmoking noncarriers of the FVL. Stroke risk was markedly higher in female smokers who had the FVL (OR, 8.8; 95% CI, 2.0 to 38.0; P=0.004) after multivariate adjustment. No such interaction was observed in men. In contrast, the frequency of the FII G20210A mutation was significantly higher in male patients compared with controls (6% versus 1%; adjusted OR, 6.1; 95% CI, 1.3 to 28.3; P=0.021). In females, the prevalence of the mutation was 3% in both groups. We found no significant interactions of the FII G20210A mutation with other vascular risk factors and stroke risk.

Conclusions— Our data indicate a highly increased risk of ischemic cerebrovascular events in women up to 60 years who smoke and have FVL. We also found evidence for an increased risk of stroke/TIA in men who have the FII G20210A mutation but not in women in this age group.

Key Words: factor V • mutation • prothrombin • stroke

This article has been cited by other articles:

				C. Sucker, C. Kurschat, G. R. Hetzel, B. Grabensee, B. Maruhn-Debowski, R. Loncar, L. Ostojic, R. E. Scharf, and R. B. Zotz The G1691A Mutation of the Factor V Gene (Factor V Leiden) and the G20210A Mutation of the Prothrombin Gene as Risk Factors in Thrombotic Microangiopathies Clinical and Applied Thrombosis/Hemostasis, June 1, 2009; 15(3): 360 - 363. [Abstract] [PDF]

				N. Botto, I. Spadoni, S. Giusti, L. Ait-Ali, R. Sicari, and M. G. Andreassi Prothrombotic Mutations as Risk Factors for Cryptogenic Ischemic Cerebrovascular Events in Young Subjects With Patent Foramen Ovale Stroke, July 1, 2007; 38(7): 2070 - 2073. [Abstract] [Full Text] [PDF]

				W. Lalouschek, G. Endler, M. Schillinger, K. Hsieh, W. Lang, S. Cheng, P. Bauer, O. Wagner, and C. Mannhalter Candidate Genetic Risk Factors of Stroke: Results of a Multilocus Genotyping Assay Clin. Chem., April 1, 2007; 53(4): 600 - 605. [Abstract] [Full Text] [PDF]

				O. Hudaoglu, S. Kurul, U. Yis, E. Dirik, H. Cakmakci, and S. Men Basilar Artery Thrombosis in a Child Heterozygous for Prothrombin Gene G20210A Mutation J Child Neurol, March 1, 2007; 22(3): 329 - 331. [Abstract] [PDF]

				E. Berge, K. B. F. Haug, E. Charlotte Sandset, K. Kristine Haugbro, M. Turkovic, and P. M. Sandset The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation Stroke, March 1, 2007; 38(3): 1069 - 1071. [Abstract] [Full Text] [PDF]

				G. J. Hankey Potential New Risk Factors for Ischemic Stroke: What Is Their Potential? Stroke, August 1, 2006; 37(8): 2181 - 2188. [Abstract] [Full Text] [PDF]